Titan Pharmaceuticals, Inc.

NasdaqCM:TTNP Stock Report

Market Cap: US$3.5m

Titan Pharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

Is Titan Pharmaceuticals (NASDAQ:TTNP) In A Good Position To Invest In Growth?

Jul 10
Is Titan Pharmaceuticals (NASDAQ:TTNP) In A Good Position To Invest In Growth?

Titan Pharma regains Nasdaq listing compliance

Dec 16

Titan Pharmaceuticals announces 1-for-30 reverse stock split

Nov 30

Titan Pharmaceuticals EPS misses by $0.01, beats on revenue

Nov 16

Titan Pharma closes debt settlement and JT-09 acquisition

Nov 02

Titan Pharma to raise $8M in stock offering

Oct 28

CEO

Titan Pharmaceuticals has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Brynner Chiam
Acting Principal Executive Officer1.1yrsUS$9.38kno data
Firdauz Bin Mokhtar
Directorless than a yearno datano data
Avraham Ben-Tzvi
Independent Director2.3yrsUS$239.91k0.36%
$ 12.7k
Francisco Osvaldo García
Directorless than a yearno datano data

1.0yrs

Average Tenure

51yo

Average Age

Experienced Board: TTNP's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.